> Skip repeated content
Dr. Thomas Lehman, Pediatric Rheumatologist

Karen Brandt Onel, MD


Pediatrics, Rheumatology
Dr. Thomas Lehman, Pediatric Rheumatologist

Karen Brandt Onel, MD


Hospital for Special Surgery
535 East 70th Street
New York, NY 10021

Tel: 212.606.1302
Fax: 212.774.7367
Hospital for Special Surgery
535 East 70th Street
New York, NY 10021

Tel: 212.606.1302
Fax: 212.774.7367

An expert in pediatric rheumatology, Karen Onel, MD, cares for children and teens with arthritis and other autoimmune disorders. In particular, she diagnoses and treats: lupus, juvenile arthritis, vasculitis, uveitis (an inflammatory disorder of the eye), chronic non-infectious osteomyelitis, dermatomyositis and the periodic fever syndromes. Her goal is to work with the patient and his/her family to create a long-term care plan that will lead to improved quality of life.

Dr. Onel's research focuses on gaining a greater understanding of the causes of rheumatic illnesses, as well as evaluating the safety and tolerability of new treatments. She is collaborating with other institutions to define evidence-based best treatment practices for children with JIA, SLE and recurrent non-infectious osteomyelitis.

Dr. Onel has authored numerous papers, reviews and book chapters on pediatric rheumatology. In addition, she serves as a reviewer for several scientific journals, including Arthritis and Rheumatism, Lupus, Seminars in Arthritis and Rheumatism and Pediatric Rheumatology.

Back in the Game Patient Stories

Appointments

Chief, Pediatric Rheumatology, Hospital for Special Surgery
Attending Physician, Hospital for Special Surgery

Specialty

Awards

Castle Connolly America's Top Doctors, 2014-2018
Castle Connolly Top Doctors in New York Metro Area, 2018
New York Magazine Top Doctors, 2018
Chicago Magazine Top Doctors, 2012, 2014, 2016
Amgen Pediatric Rheumatology Visiting Professorship, 2014, 2015
Chicago Arthritis Walk Medical Honoree, 2013
ACR Pediatric Rheumatology Research Award, 1994
Fellowship ACR Senior Rheumatology Scholar Award, 1994
Mitchell Spivak Memorial Prize in Pediatrics, 1989
Janet M. Glasgow Memorial Achievement Citation, 1989
Alpha Omega Alpha, 1988

Languages

English, Spanish

Insurance Information

Aetna
Blue Cross Blue Shield PPO HMO POS
Blue Cross Blue Shield Pathway
Blue Cross Blue Shield Pathway Enhanced
Cigna
Connecticare
Emblem Selectcare
HIP
Medicare
Oxford
Oxford Medicare
United Healthcare
United Healthcare Compass

Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.

Book an Appointment

Dr. Onel accepts the following insurance plans:

Aetna
Blue Cross Blue Shield PPO HMO POS
Blue Cross Blue Shield Pathway
Blue Cross Blue Shield Pathway Enhanced
Cigna
Connecticare
Emblem Selectcare
HIP
Medicare
Oxford
Oxford Medicare
United Healthcare
United Healthcare Compass

Please note, if your insurance is not on this list, you may still have coverage subject to the availability of out-of-network benefits.

If you do not wish to go out-of-network, our Physician Referral Service will help you find an appropriate doctor.

Education

Cornell University Medical College, New York

Internship

Columbia Presbyterian Medical Center, New York

Residency

Columbia Presbyterian Medical Center, New York

Fellowship

Hospital for Special Surgery, New York

Certification

Pediatrics
Pediatric Rheumatology

State Licensure

New York, Illinois

Patient Education by Dr. Onel on HSS.edu

Selected Publications

Brunner HI, Bennett M, Abulaban K, Klein-Gitelman M, O'Neil K, Tucker L, Ardoin S, Rouster-Stevens K, Onel KB, Singer N, Eberhard BA, Jung L, Imundo L, Wright T, Witte D, Rovin B, Ying J, and Devarajan P. Development of a novel renal activity index of lupus nephritis in children & young adults. Arthritis Care Res (Hoboken). July; 68(7):1003-1011, 2016

Knight A, Vickery M, Muscal E, Davis A, Harris JG, Soybilgic A, Onel K, Schanberg LE, Rubinstein T, Gottlieb BS, Mandell DS, and von Scheven E. Identifying Targets for Improving Mental Health Care of Adolescents with Lupus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada
J Rheumatol. Jun;43(6):1136-45, 2016

Mina R, Abulaban K, Klein-Gitelman M, Eberhard A, Ardoin S, Singer N, Onel KB, Tucker L, O'Neil K, Wright T, Brooks E, Rouster-Stevens K, Jung L, Imundo L, Rovin B, Witte D, Ying J, and Brunner HI. Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus. Arthritis Care Res. Feb;68(2):195-202, 2016

Ringold S, Hendrickson A, Abramson L, Beukelman T, Blier PR, Bohnsack J, Chalom EC, Gewanter HL, Gottlieb B, Hollister R, Hsu J, Hudgins A, Ilowite NT, Klein-Gitelman M, Lindsley C, LopezBenitez JM, Lovell DJ, Mason T, Milojevic D, Moorthy LN, Nanda K, Onel KB et al. A novel method to collect medication adverse events in juvenile arthritis: Results from the Childhood Arthritis and rheumatology research alliance enhanced drug safety surveillance project (EDSSP). Arthritis Care Res. Apr; 67(4):529-37, 2015.

Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel KB, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, and Brunner HI. Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus. Lupus. Feb;24(2):191-7, 2015.

Sobel, RE, Lovell DJ, Brunner HI, Weiss JE, Morris PW, Gottlieb BS, Chalom EC, Jung LK, Onel KB, Petiniot L, Goldsmith DP, Nanda K, Shishov M, Abramsky S, Young JP, and Giannini EH. Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry. Pediatr Rheumatol. 12:29. 2014.

Soybilgic A, Tesher M, Wagner-Weiner L, and Onel KB. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America. Pediatr Rheumatol. 12:24. 2014.

Ringold S, Weiss PF, Colbert RA, Dewitt EM, Lee T, Onel KB, Prahalad S, Schneider R, Shenoi S, Vehe RK, and Kimura Y. Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res. Jul;66(7):1063-72, 2014.

Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel KB, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Martini A, Ruperto N, Lovell D, and Brunner, HI. Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus. Ann Rheum Dis. Feb 73(2):401-6, 2014.

Soybilgic, A, Onel KB, Utset T, Alexander K, and Wagner-Weiner L. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years. Pediatr Rheumatol Online J. Aug 7;11:29 2013.

Lovell DJ, Giannini EH, Reiff AO, Kimura Y, Li S, Hashkes PJ, Wallace CA, Onel KB, Foell D, Wu R, Biedermann S, Hamilton JD, and Radin AR. Long-Term Safety and Efficacy of Rilonacept in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA). Arthritis Rheum. Sep;65:2486-96, 2013.

For more publications, please see the PubMed listing.

Selected Presentations

2015 Update in Juvenile Idiopathic Arthritis: Where Are We? Pediatric Grand Rounds, Children's Hospital of Illinois, Peoria, IL

2015 Update in Juvenile Idiopathic Arthritis: Where Are We? Pediatric Grand Rounds, Nationwide Children's Hospital, Columbus, OH

How to get what you need from your doctors and nurses. Improving Your Health Experience," Lupus Foundation of America (speaker and course organizer), Chicago, IL

Inactive Disease in Systematic Juvenile Idiopathic Arthritis. CARRA Annual Scientific Meeting, Austin, TX

2014 Update in Juvenile Idiopathic Arthritis: Where Are We? Pediatric Grand Rounds, University of Miami, Miami, FL

2014 Update in Juvenile Idiopathic Arthritis: Where Are We? Pediatric Grand Rounds, William Beaumont Hospital, Royal Oak, MI

2014 Update in Juvenile Idiopathic Arthritis: Where Are We? Rheumatology Grand Rounds, Rush University Medical Center, Chicago, IL

Systemic Juvenile Idiopathic arthritis and your child. Juvenile Arthritis Conference, St. Louis, MO

2011 Update in Juvenile Idiopathic Arthritis: Where Are We? Pediatric Grand Rounds, Edwards Hospital, Naperville, IL

Research Interests

Current interests include:

  • Collaborative Clinical Trials in JIA and SLE
  • Treatment for Chronic Recurrent Multifocal Osteomyelitis
  • Analysis of Cardiopulmonary involvement in Systemic JIA
  • Assessment of Mental Health needs for young people with SLE
  • Treatment withdrawal and remission for children with Systemic JIA

Patient Registries